Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Preclinical data show AdCOVID neutralizes SARS-CoV-2 B.1.351 variant

May 28, 2021

OSE's COVID-19 vaccine CoVepiT enters first-in-human study

May 28, 2021

Phase II results of suvratoxumab to prevent S. aureus ventilator-associated pneumonia

May 28, 2021

Study casts new light on chronic HCV infection

May 27, 2021

Start of phase II/III EMPATHY trial of ensovibep for treatment of COVID-19

May 27, 2021

Prosit Sole initiates phase I study of interferon lambda chimera injection PSP-001

May 27, 2021

Results published from trial evaluating a therapeutic based on equine polyclonal Abs for COVID-19

May 26, 2021

NextCell Pharma initiates phase I study of ProTrans in patients with COVID-19

May 26, 2021

Recursion initiates IND-enabling studies of its novel small molecule toxin inhibitor

May 26, 2021

Pilot study evaluates NT-I7 in progressive multifocal leukoencephalopathy

May 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...